Novartis Surpasses Q4 Earnings Estimates, Driven by Strong Sales Growth

Novartis AG, the Swiss multinational pharmaceutical company, has reported strong financial results for the fourth quarter of 2023, surpassing consensus estimates. The company's robust performance was driven by robust sales growth, core operating income margin expansion, and innovation milestones. Here's a closer look at the key factors contributing to Novartis' earnings growth and its long-term prospects.